These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12419016)

  • 1. Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites.
    Zhao XJ; Jones DR; Wang YH; Grimm SW; Hall SD
    Xenobiotica; 2002 Oct; 32(10):863-78. PubMed ID: 12419016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
    Jones DR; Gorski JC; Hamman MA; Mayhew BS; Rider S; Hall SD
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1116-25. PubMed ID: 10454485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the impact of CYP3A polymorphisms on the formation of α-hydroxytamoxifen and N-desmethyltamoxifen in human liver microsomes.
    Mugundu GM; Sallans L; Guo Y; Shaughnessy EA; Desai PB
    Drug Metab Dispos; 2012 Feb; 40(2):389-96. PubMed ID: 22096084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
    Ma B; Prueksaritanont T; Lin JH
    Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
    Williams JA; Ring BJ; Cantrell VE; Jones DR; Eckstein J; Ruterbories K; Hamman MA; Hall SD; Wrighton SA
    Drug Metab Dispos; 2002 Aug; 30(8):883-91. PubMed ID: 12124305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP3A5 Contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects.
    Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Honda G; Nakagawa K; Ishizaki T; Kamataki T
    Drug Metab Pharmacokinet; 2004 Apr; 19(2):120-9. PubMed ID: 15499178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil.
    Wang YH; Jones DR; Hall SD
    Drug Metab Dispos; 2005 May; 33(5):664-71. PubMed ID: 15689501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based inactivation of CYP3A by HIV protease inhibitors.
    Ernest CS; Hall SD; Jones DR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):583-91. PubMed ID: 15523003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.
    Notley LM; Crewe KH; Taylor PJ; Lennard MS; Gillam EM
    Chem Res Toxicol; 2005 Oct; 18(10):1611-8. PubMed ID: 16533026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes.
    Crewe HK; Ellis SW; Lennard MS; Tucker GT
    Biochem Pharmacol; 1997 Jan; 53(2):171-8. PubMed ID: 9037249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential enantioselectivity and product-dependent activation and inhibition in metabolism of verapamil by human CYP3As.
    Shen L; Fitzloff JF; Cook CS
    Drug Metab Dispos; 2004 Feb; 32(2):186-96. PubMed ID: 14744940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.
    Mäenpää J; Hall SD; Ring BJ; Strom SC; Wrighton SA
    Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5.
    Cook CS; Berry LM; Kim DH; Burton EG; Hribar JD; Zhang L
    Drug Metab Dispos; 2002 Dec; 30(12):1344-51. PubMed ID: 12433801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.
    Hamaoka N; Oda Y; Hase I; Asada A
    Br J Anaesth; 2001 Apr; 86(4):540-4. PubMed ID: 11573629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
    Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
    Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
    Sutton D; Butler AM; Nadin L; Murray M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and pharmacokinetic evaluation of rat hepatic and gastrointestinal cytochrome p450 induction by tamoxifen.
    Cotreau MM; von Moltke LL; Harmatz JS; Greenblatt DJ
    Pharmacology; 2001; 63(4):210-9. PubMed ID: 11729359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
    Pinto AG; Wang YH; Chalasani N; Skaar T; Kolwankar D; Gorski JC; Liangpunsakul S; Hamman MA; Arefayene M; Hall SD
    Clin Pharmacol Ther; 2005 Mar; 77(3):178-88. PubMed ID: 15735612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6.
    Boek-Dohalská L; Hodek P; Sulc M; Stiborová M
    Chem Biol Interact; 2001 Oct; 138(1):85-106. PubMed ID: 11640917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Xenobiotica; 2001 Oct; 31(10):713-23. PubMed ID: 11695850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.